Toxicology Track Information
Programs in the toxicology concentration are
designed to prepare students for technical, professional, and supervisory
positions and careers in academic institutions, public agencies, and
industry. The curriculum emphasizes the application of multidisciplinary
approaches to solve public health problems associated with toxic
chemicals. Research specializations are available in many areas,
including adverse drug response, biomarkers, microbiology, neurotoxicology,
molecular toxicology, chemical carcinogenesis, nanotoxicology, and
immunotoxicology. The program is flexible and will reflect the individual
needs of the student.
Xinxin Ding, Ph.D., University of Michigan (1988)
Molecular toxicology; pharmacogenetics; gene regulation and biological function of cytochrome P-450 monooxygenases; transgenic/knockout mouse models of human disease.
Ellen Braun-Howland, Ph.D., Rensselaer Polytechnic Institute (1982)
Occurrence and control of pathogens in the environment; molecular detection of environmentally significant organisms.
David Carpenter, M.D., Harvard University (1964)
Neurotoxicity of metals (Pb, Hg) and PCBs using electrophysiological and flow cytometric techniques.
Jun Gu, Ph.D., Shanghai Medical University (1993)
The mechanisms of environmental diseases and chemical toxicity.
Bruce J. Herron, Ph.D., University at Albany, State University of New York (1999)
Functional analysis of the mouse genome: Investigation of defects in mammalian organogenesis.
David Lawrence, Ph.D., Boston College (1971)
Cellular, molecular, and biochemical investigation of the effects of environmental factors on the immune system; regulatory interactions between the nervous and immune systems.
Veronica Miller, Ph.D., University of Newcastle-upon-Tyne, United Kingdom (2007)
My research focuses into the role of environmental contaminants and immune responses in developmental and brain aging diseases with a focus on autism and dementia.
Ramune Reliene, Ph.D., Swiss Federal Institute of Technology (ETH) Zurich (2001)
Gene, environment and nutrient interactions in the etiology and prevention of cancer.
Richard F. Seegal, Ph.D., University of Georgia (1972)
Developmental neurotoxicity of PCBs and heavy metals; neuroimmune interactions and Parkinson's disease.
David Spink, Ph.D., University of Maryland (1983)
Effects of xenobiotics on the metabolism of drugs and steroid hormones.
Robert Turesky, Ph.D., Massachusetts Institute of Technology (1986)
Environmental and molecular epidemiology; assessment of human exposure to toxicants; biochemical toxicology of carcinogenic heterocyclic aromatic amines.
JoEllen Welsh, Ph.D., Cornell University (1980)
Nutrition, nuclear receptors, genomics and cancer using cellular and whole animal approaches; the molecular mechanisms by which dietary-derived nuclear receptor ligands reduce the risk of breast cancer development.
Qing-Yu Zhang, Ph.D., University of Michigan (1989)
Intestinal P450 enzymes in drug metabolism and chemical toxicity; regulation and biological functions of tissue-selective drug metabolism enzymes.
Sara Brenner, M.D., University of Iowa (2006), M.P.H., University at Albany, State University of New York (2008)
Occupational and environmental health effects of exposure to engineered nanomaterials; Epidemiology and medical surveillance of the nanoelectronics workforce; Nanotoxicology; Ethical, legal, and societal implications of nanotechnology; Nanomedicine
Anwar Y. Dunbar, Ph.D., University of Michigan (2005)
Laurence S. Kaminsky, Ph.D., Cape Town University, South Africa (1966)
Brian Mayes, Ph.D., Albany Medical College (1979)
Brian Pentecost, Ph.D., University of London (1981)
Control of steroid receptor expression including estrogen receptor and the PXR/RXR which regulates human Cytochrome P4503A4.
Robert A. Waniewski, Ph.D., George Washington University (1980)